Cash Flow Statement

Amortizatization of Intangibles Amortizatization of Intangibles Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Receivables Change in Receivables Depreciation & Amortization (CF)Depreciation & Amortization (CF)Divestments Dividends Paid - Common Dividends Paid - Common Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances

Growth Metrics

Pharma-Bio Serv (PBSV) Cash from Discontinued Operations (2018)

Pharma-Bio Serv's Cash from Discontinued Operations history spans 1 years, with the latest figure at 325159.0 for Q4 2018.

For Q4 2018, Cash from Discontinued Operations changed N/A year-over-year to 325159.0; the TTM value through Jul 2019 reached 325159.0, changed N/A, while the annual FY2018 figure was 728726.0, 192.75% up from the prior year.
Cash from Discontinued Operations reached 325159.0 in Q4 2018 per PBSV's latest filing, down from 559219.0 in the prior quarter.
In the past five years, Cash from Discontinued Operations ranged from a high of 559219.0 in Q3 2018 to a low of 277995.0 in Q2 2018.